P. Zuck

发表

[Profile and management of patients consulting for a non severe exacerbation of chronic obstructive pulmonary disease (Pragma survey)].

C. Perronne, P. Léophonte, P. Zuck, 2008, Medecine et maladies infectieuses.

Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.

K. Cheeseman, J. Ostinelli, J. Piquet, 1996, Advances in therapy.

Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment

P. Nikolaides, R. Finch, J. Izquierdo, 2002, Antimicrobial Agents and Chemotherapy.

[Routine use of extended-release clarithromycin tablets for short-course treatment of acute exacerbations of non-severe COPD].

C. Perronne, P. Léophonte, P. Zuck, 2008, Medecine et maladies infectieuses.

Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.

D. Benhamou, A. Cuvelier, J. Muir, 2002, Respiratory care.

Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis.

A. Novelli, P. Periti, P. Zuck, 1990, The Journal of antimicrobial chemotherapy.

[Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess. Apropos of 57 cases].

C. Brambilla, J. Guerin, C. Boutin, 1993, Revue de pneumologie clinique.

[Treatment of community-acquired pneumonia with levofloxacin: 500 mg once a day or 500 mg twice a day?].

J. Bru, P. Zuck, 2000, Presse medicale.

[Relevance of fluoroquinolone use in Lorraine: results of the first survey].

T. Doco‐Lecompte, B. Demoré, C. Rabaud, 2010, Medecine et maladies infectieuses.

Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia.

P. Zuck, Y. Rio, F. Ichou, 1990, The Journal of antimicrobial chemotherapy.

Piroxicam induced pulmonary infiltrates and eosinophilia.

M. Meier, P. Pfitzenmeyer, A. Turcu, 1994, The Journal of rheumatology.

P. Zuck, 1978, Acta Endoscopica.

Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors

C. Brambilla, F. Paganin, H. Portier, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

A double-blind randomized trial comparing the efficacy and safety of a 5-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis caused by group A β-haemolytic streptococci

Claude Carbón, E. Bingen, P. Zuck, 1995 .

A double-blind randomized trial comparing the efficacy and safety of a 5-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis caused by group A beta-haemolytic streptococci.

Claude Carbón, E. Bingen, P. Zuck, 1995, Journal of Antimicrobial Chemotherapy.

Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.

M. Šmakal, C. Marr, H. Staley, 1999, The Journal of antimicrobial chemotherapy.